RT Journal Article
SR Electronic
T1 Development of Predictive Risk Models for All-cause Mortality in Pulmonary Hypertension using Machine Learning
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.16.21249934
DO 10.1101/2021.01.16.21249934
A1 Zhou, Jiandong
A1 Wong, Ka Hei Gabriel
A1 Lee, Sharen
A1 Liu, Tong
A1 Kit Leung, Keith Sai
A1 Jeevaratnam, Kamalan
A1 Yung Cheung, Bernard Man
A1 Kei Wong, Ian Chi
A1 Zhang, Qingpeng
A1 Tse, Gary
YR 2021
UL http://medrxiv.org/content/early/2021/01/20/2021.01.16.21249934.abstract
AB Background Pulmonary hypertension, a progressive lung disorder with symptoms such as breathlessness and loss of exercise capacity, is highly debilitating and has a negative impact on the quality of life. In this study, we examined whether a multi-parametric approach using machine learning can improve mortality prediction.Methods A population-based territory-wide cohort of pulmonary hypertension patients from January 1, 2000 to December 31, 2017 were retrospectively analyzed. Significant predictors of all-cause mortality were identified. Easy-to-use frailty indexes predicting primary and secondary pulmonary hypertension were derived and stratification performances of the derived scores were compared. A factorization machine model was used for the development of an accurate predictive risk model and the results were compared to multivariate logistic regression, support vector machine, random forests, and multilayer perceptron.Results The cohorts consist of 2562 patients with either primary (n=1009) or secondary (n=1553) pulmonary hypertension. Multivariate Cox regression showed that age, prior cardiovascular, respiratory and kidney diseases, hypertension, number of emergency readmissions within 28 days of discharge were all predictors of all-cause mortality. Easy-to-use frailty scores were developed from Cox regression. A factorization machine model demonstrates superior risk prediction improvements for both primary (precision: 0.90, recall: 0.89, F1-score: 0.91, AUC: 0.91) and secondary pulmonary hypertension (precision: 0.87, recall: 0.86, F1-score: 0.89, AUC: 0.88) patients.Conclusion We derived easy-to-use frailty scores predicting mortality in primary and secondary pulmonary hypertension. A machine learning model incorporating multi-modality clinical data significantly improves risk stratification performance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by The Joint Chinese University of Hong Kong - New Territories East Cluster Clinical Research Ethics Committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available upon request.